News
Owlstone Medical Enters into a Research Collaboration Agreement with the FDA to Support the Confident Identification of Volatile Organic Compounds on Breath and Expansion of its Breath Biopsy VOC Atlas®
30 Sep 2024
Read More
Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors
Read More
14 Sep 2018
Breath Biopsy platform scoops the UK’s most prestigious award for engineering innovation
Read More
27 Jul 2018
Owlstone Medical Appoints Five Leading Experts to Scientific Advisory Board
Read More
19 Jul 2018
Owlstone Medical provides Breath Biopsy Services to AstraZeneca to study disease drivers in Asthma and COPD
Read More
9 Apr 2018
Owlstone Medical launches Breath Biopsy Kits
Read More
28 Mar 2018
Owlstone Medical raises $15 million USD (£11 million GBP) with Horizons Ventures and Aviva
Read More
5 Mar 2018
Owlstone Medical’s Breath Biopsy Wins Global IPF Catalyst Challenge
Read More
25 Jan 2018
The Economist: Follow Your Nose
Read More
1 Dec 2017
Owlstone Medical’s Breath Biopsy Platform integrated into GSK’s Phase II Respiratory Disease Clinical Trial
Read More
27 Nov 2017
Breath Biopsy® in The Economist’s Cancer Technology Quarterly
Read More
15 Sep 2017
Owlstone Medical’s disease breathalyzer, ReCIVA, to feature in Tomorrow’s World gallery at the Science Museum, London
Read More
22 Aug 2017
Owlstone Medical and Cancer Research UK (CRUK) Initiate Pan Cancer Clinical Trial to Evaluate Breath Biopsy for Early Detection of Disease
Read More
10 Jul 2017